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TO THE EDITOR 
 
Many diseases are caused by single amino acid substitutions on key genes due to loss of 
stability, protein misfolding and changes in the interaction properties (Goldberg, 2003; Honig 
and Nicholls, 1995). Protein structures can be used to evaluate the effect of missense mutations 
on disease associated proteins, especially on highly polymorphic genes, where functional 
studies are likely to be incomplete.  
Considering the involvement of the highly polymorphic melanocortin-1 receptor gene 
(MC1R) in melanoma predisposition, we investigated the role of the rare variants (minor allele 
frequency <1%) found in this gene in the Spanish population. A structural analysis was 
performed by evaluating the amino acid substitutions in the context of a three-dimensional 
model and comparing their effects with available functional data.  
The MC1R gene, which is located on chromosome 16q24.3 and codes for a melanocyte-
stimulating hormone receptor with seven transmembrane helices, is to date, the main genetic 
contributor to sporadic melanoma predisposition (Kennedy et al., 2001). It has already been 
associated to melanoma in different Caucasian populations (Fernandez et al., 2007; Ibarrola-
Villava et al., 2010; Ibarrola-Villava et al., 2012). It is highly polymorphic, with more than 100 
non-conservative reported variants (Gerstenblith et al., 2007). Most of these changes are 
relatively rare, but their frequencies vary among populations, and it appears that they are more 
commonly found in South European populations than in those of North European descent 
(Gerstenblith et al., 2007; Williams et al., 2011).  
Of the 1170 individuals sequenced (710 non-related melanoma cases and 460 cancer-
free controls), 697 (59.6%) carried at least one MC1R variant, with 78 (11.2%) of them actually 
carrying a rare variant. Overall, 6.7% (78 of 1170 individuals) of the Spanish population carry 
an MC1R rare variant. We detected a total of 41 different MC1R variants. Among these, 31 
variants appear rarely in Spain and variant Y298H appeared for the first time in our population. 
We have obtained statistically significant individual associations with melanoma for six 
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variants: V60L, S83P, R151C, I155T, R160W and D294H (Supplementary Table S1). The 
highest OR was estimated for I155T and R160W (OR: 3.81; p-value=0.003 and OR: 3.83; p-
value=0.001 respectively). The estimated OR associated with carrying at least one non-
synonymous variant was 1.79 (p-value = 4.93x10-11). However, the OR for carrying only one 
rare variant was 0.97 (p-value = 0.93). There are many common non-synonymous MC1R 
variants associated with a red hair colour (RHC) phenotype: D84E, R142H, R151C, I155T, 
R160W and D294H. The association of other common variants such as V60L, V92M and 
R163Q with the RHC phenotype has not been clearly established, and therefore these variants 
have been considered non-red hair colour (NRHC) (Wong and Rees, 2005). Almost all carriers 
of rare changes in the Spanish population tend to have fair skin colour. However, only 40% of 
them also harboured an RHC or NRHC variant. Thus, rare variants might slightly modulate skin 
pigmentation.  
Different studies have demonstrated the functional consequences of some of these 
MC1R changes. Thus, mutations in positions 84, 142, 151, 160 and 294 have been previously 
reported to alter protein function (Dessinioti et al., 2011; Garcia-Borron et al., 2005; Newton et 
al., 2007; Ringholm et al., 2004; Sanchez-Laorden et al., 2009). In addition, previous functional 
studies have validated some of the 3D model prediction results. Position M128 appears to have 
no effect according to in silico predictions; however, the 3D model suggests it could be a 
putative folding disrupter, later confirmed in a functional study (Perez Oliva et al., 2009).  
 Due to the importance of MC1R variants in pigmentation and melanoma predisposition 
we have undertaken a comprehensive three-dimensional structure modelling of 29 non-
synonymous changes detected in our population in order to further explain putative implications 
of rare variants (Table 1 and Figure 1). After evaluating all changes according to MC1R 
structure, variant location and nature of the amino acid changes, 25 variants seemed to have 
structural implications and cluster in three different regions that may explain their differences in 
functionality: the GTPase/PKC signalling region, an alleged α-MSH-binding extracellular 
region, and a novel central core protein region. The first and better-known region harbours some 
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of the common RHC (R142H, R151C, I155T and R160W) and NRHC (R163Q) variants. 
Although these variants do not seem to bring about structural changes under the 3D-model, they 
are located in an intracellular region thought to be a GTPase and PKC interaction area that 
initiates the receptor downstream signalling pathway and internalization of the receptor which 
confirms previously reported functionality (Dessinioti et al., 2011; Garcia-Borron et al., 2005; 
Newton et al., 2007). Interestingly, side chains of residues I155, T157, R160 and R163 define a 
common solvent accessible area, a PKC binding domain comprising 157TLPR160 and 160ARR163 
(Sanchez-Laorden et al., 2009), and therefore, variants in these positions could explain 
impairment of PKC activity. Rare variants R142C, R213W and T308M are located near this 
region.  
The second important region includes the rest of the RHC (D84E and D294H) and NRHC 
(V60L and V92M) variants, plus other rare variants (S83P, G89R, M128T and Y298H). 
Variants located in this central region may be involved in protein folding processes, and 
therefore may be important in the maintenance of the receptor’s integrity.  
Finally, we propose a third new functional region which includes S41F, P268R, T272M, 
K278E, N281S and A285V rare variants. All except S41F are located in the extracellular end 
helical tips and though there is no evident structural implication, we believe this domain may be 
involved in α-MSH union (Perez Oliva et al., 2009).  
Rare variants located in positions 41, 128, 89, 213 and 308 are described to alter protein 
function (Ozola et al., 2013; Perez Oliva et al., 2009; Sanchez-Laorden et al., 2007). M128T 
and R213W showed markedly loss of function and displayed reduced cell surface expression 
and agonist binding affinity while variants S41F and G89R showed almost complete loss of 
function with no detectable cell surface expression and complete inability to activate the cAMP 
pathway. Finally, residue T308 is described to be implicated in protein phosphorilation. 
Therefore, the ensuing outcomes of this MC1R variant modelling are highly consistent with data 
from previously published functional MC1R studies. 
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  To sum up, changes S41F, S83P, G89R, R142C, M128T, R213W, P268R, Y298H and 
T308M (Figure 1b, highlighted in deep blue) are predicted to have structural consequences, 
while variants T272M, K278E, N279K, N281S and A285V (Figure 1b highlighted in cyan) may 
have mild or no structural implications, but may be potentially important for protein recognition 
due to their near extracellular location. SNP3d in silico predictions represent a useful tool to 
evaluate amino acid change effects in a protein structure. However, they can only discriminate 
between damaging or benign effect. Our model combines folding effects, nature of the amino 
acid substitution and location of both individual variants and clusters.. The use of 3D models 
may constitute a robust and exploratory prediction method, as it combines folding and 
visualization of the amino acid changes, and therefore could be a promising tool in order to 
assess further functional MC1R variant studies. To our knowledge, this is the first time that a 
large number of rare MC1R variants are evaluated by taking into account the structural effects 
of the resulting residue changes.   
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V60L (r)  Benign    F  Conserved change No effect Yes Core 
D84E (R)  Affect    F  Conserved charge larger residue Affect No Core 
V92M (r)  Benign    NF  Conserved change No effect No ‐ 
R142H (R)  Affect    F  Cytosolic conserved No effect No PKC/GTPase sig. 
R151C (R)  Affect    F  Cytosolic non conserved No effect Yes PKC/GTPase sig. 
I155T (R)  Affect    F  Cytosolic non conserved No effect Yes PKC/GTPase sig. 
R160W (R)  Affect    F  Cytosolic conserved No effect Yes PKC/GTPase sig. 
R163Q (r)  Benign    F  Cytosolic conserved No effect Yes PKC/GTPase sig. 
D294H (R)  Affect    F  Charge change Affect No Core 
C35Y  Affect    F  Non conserved No effect Yes ‐ 
S41C  Affect    ‐  Conserved change No effect No MSH binding 
S41F  Affect    F  Bulkier hydrophobic change Affect No MSH binding 
F45L  Affect    ‐  Conserved change No effect No ‐ 
S83P  Affect    ‐  Induces distortion of helix 2 Affect No Core 
G89R  Affect    F  Charged bulkier residue Affect Yes Core 
V92L  Benign    ‐  Conserved change No effect No Core 
T95M  Affect    ‐  Conserved change No effect No ‐ 
V122M  Benign    ‐  Conserved change No effect Yes ‐ 
M128T  Benign    F  Hydrophobic to small polar Affect No Core 
R142C  Affect    ‐  Non conserved Affect No PKC/GTPase sig. 
R213W  Affect    F  Bulky hydrophobic replacement  Affect Yes PKC/GTPase sig. 
P268R  Affect    ‐  Charged bulkier residue Affect Yes MSH binding 
T272M  Affect    F  Change to large apolar No effect Yes MSH binding 
K278E  Benign    ‐  Charge change No effect Yes MSH binding 
N279K  Affect    ‐  Non conserved change No effect Yes MSH binding 
N281S  Affect    NF  Change to smaller residue No effect Yes MSH binding 
A285V  Benign    ‐  Bulkier residue No effect Yes MSH binding 
Y298H  Affect    ‐  Charge change Affect No Core 























Figure 1: MC1R three-dimensional model. Representation of 25 non-synonymous 
variants described in the Spanish population. a) Location of Red Hair Color (RHC) and Non 
Red Hair Color (NRHC) variants. Positions RHC are colored in red whereas NRHC are colored 
in orange. b) Location of potentially-functional rare variants according to their structure. 
Positions colored in deep blue and cyan. c) Magnification of receptor’s core central region. d) 
Detail of important residues in PKC MC1R binding domain. Residues are colored according to 
atom nature. Oxygen in red and nitrogen in purple. 
 
 
 
 
 
 
 
 
 
 
 
 
